HST Global Inc. Depreciation & Amortization

Depreciation & Amortization of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization for the quarter ending December 30, 2011 was $100 (a -50.0% decrease compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization decreased by 0.0%
  • Annual Depreciation & Amortization for 2011 was $500 (a -50.0% decrease from previous year)
  • Annual Depreciation & Amortization for 2010 was $1 Thousand (a 0.0% decrease from previous year)
  • Twelve month Depreciation & Amortization ending December 30, 2011 was $500 (a 25.0% increase compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization decreased by -54.55% year-over-year
Trailing Depreciation & Amortization for the last four month:
30 Dec '11 29 Sep '11 29 Jun '11 30 Mar '11
$500 $400 $1.2 Thousand $1.1 Thousand
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization of HST Global Inc.

Most recent Depreciation & Amortizationof HSTC including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization of HST Global Inc.

HST Global Inc. Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2011 $0.0 $0.0 $0.0 $0.0 $0.0
2010 $0.0 $0.0 $0.0 $0.0 $0.0
2009 $0.0 $0.0

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.